NM_005535.3:c.139C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005535.3(IL12RB1):​c.139C>T​(p.Pro47Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00234 in 1,610,706 control chromosomes in the GnomAD database, including 104 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 59 hom., cov: 31)
Exomes 𝑓: 0.0012 ( 45 hom. )

Consequence

IL12RB1
NM_005535.3 missense

Scores

3
4
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.37

Publications

6 publications found
Variant links:
Genes affected
IL12RB1 (HGNC:5971): (interleukin 12 receptor subunit beta 1) The protein encoded by this gene is a type I transmembrane protein that belongs to the hemopoietin receptor superfamily. This protein binds to interleukine 12 (IL12) with a low affinity, and is thought to be a part of IL12 receptor complex. This protein forms a disulfide-linked oligomer, which is required for its IL12 binding activity. The coexpression of this and IL12RB2 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. Mutations in this gene impair the development of interleukin-17-producing T lymphocytes and result in increased susceptibility to mycobacterial and Salmonella infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
IL12RB1 Gene-Disease associations (from GenCC):
  • Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004633844).
BP6
Variant 19-18082250-G-A is Benign according to our data. Variant chr19-18082250-G-A is described in ClinVar as Benign. ClinVar VariationId is 328604.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0131 (1998/152230) while in subpopulation AFR AF = 0.0456 (1896/41534). AF 95% confidence interval is 0.0439. There are 59 homozygotes in GnomAd4. There are 949 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 59 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL12RB1NM_005535.3 linkc.139C>T p.Pro47Ser missense_variant Exon 3 of 17 ENST00000593993.7 NP_005526.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL12RB1ENST00000593993.7 linkc.139C>T p.Pro47Ser missense_variant Exon 3 of 17 1 NM_005535.3 ENSP00000472165.2

Frequencies

GnomAD3 genomes
AF:
0.0131
AC:
1991
AN:
152112
Hom.:
59
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0456
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00491
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00333
AC:
827
AN:
248038
AF XY:
0.00256
show subpopulations
Gnomad AFR exome
AF:
0.0457
Gnomad AMR exome
AF:
0.00222
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000134
Gnomad OTH exome
AF:
0.000992
GnomAD4 exome
AF:
0.00122
AC:
1778
AN:
1458476
Hom.:
45
Cov.:
30
AF XY:
0.00106
AC XY:
770
AN XY:
725682
show subpopulations
African (AFR)
AF:
0.0436
AC:
1457
AN:
33420
American (AMR)
AF:
0.00252
AC:
112
AN:
44494
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26078
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39630
South Asian (SAS)
AF:
0.0000582
AC:
5
AN:
85934
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53314
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000288
AC:
32
AN:
1109560
Other (OTH)
AF:
0.00275
AC:
166
AN:
60282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
82
164
246
328
410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0131
AC:
1998
AN:
152230
Hom.:
59
Cov.:
31
AF XY:
0.0128
AC XY:
949
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0456
AC:
1896
AN:
41534
American (AMR)
AF:
0.00484
AC:
74
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68014
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
97
194
291
388
485
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00692
Hom.:
27
Bravo
AF:
0.0148
ESP6500AA
AF:
0.0477
AC:
210
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00428
AC:
520
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.39
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
D;D;.;.;.;.
Eigen
Uncertain
0.32
Eigen_PC
Benign
0.18
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.83
.;T;T;T;T;T
MetaRNN
Benign
0.0046
T;T;T;T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Uncertain
2.7
M;M;M;.;.;.
PhyloP100
4.4
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-4.2
.;.;D;.;.;.
REVEL
Benign
0.24
Sift4G
Pathogenic
0.0
D;D;D;.;.;.
Polyphen
1.0
D;D;P;.;.;.
Vest4
0.60
MVP
0.88
MPC
0.47
ClinPred
0.059
T
GERP RS
2.8
Varity_R
0.28
gMVP
0.85
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17887176; hg19: chr19-18193060; API